European Medicines Agency sets up task force for use of big data in medicine
The European Medicines Agency (EMA) has set up a new task force together with the heads of the national competent authorities in the European Economic Area (Heads of Medicines Agencies) to deal with the use of big data in medicine. The objective of the task force is to explore how medicines regulators in the EEA can use big data to support research, innovation and robust medicines development in order to benefit human and animal health.
The task force is chaired by the Danish Medicines Agency and EMA. Its members are experienced staff from medicines regulatory agencies in the EEA. The task force will also involve external experts on an ad hoc basis in big data collection analysis. Over the next 18 months, the task force will work on establishing a roadmap for the development of big data capabilities and recommendations for the use of big data in the assessment of medicines, including recommendations on necessary changes to legislation, regulatory guidelines or data security provisions;
For more information: